Andrea F. Wainer - 23 Dec 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
23 Dec 2021
Net transactions value
-$1,581,500
Form type
4
Filing time
28 Dec 2021, 16:41:13 UTC
Previous filing
21 Dec 2021
Next filing
23 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $141,000 +3,000 +6% $47.00 52,782 23 Dec 2021 Direct
transaction ABT Common shares without par value Options Exercise $384,000 +10,000 +19% $38.40 62,782 23 Dec 2021 Direct
transaction ABT Common shares without par value Sale $1,820,000 -13,000 -21% $140.00 49,782 23 Dec 2021 Direct
transaction ABT Common shares without par value Options Exercise $141,000 +3,000 +6% $47.00 52,782 27 Dec 2021 Direct
transaction ABT Common shares without par value Sale $427,500 -3,000 -5.7% $142.50 49,782 27 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -3,000 -21% $0.000000 11,226 23 Dec 2021 Common Shares 3,000 $47.00 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -10,000 -67% $0.000000 5,000 23 Dec 2021 Common Shares 10,000 $38.40 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -3,000 -27% $0.000000 8,226 27 Dec 2021 Common Shares 3,000 $47.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).